Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magic solution mouth care for prevention and management of chemotherapy-related oral mucositis
IRCT20230119057156N1Phase 3Completed
- Sponsor
- University of Karbala
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of chlorhexidine, nystatin, tetracycline and glycerol in stomatitis (2 arms), sponsored by University of Karbala. Primary endpoints: Change in oral mucositis severity, Change in oral toxicity and 2 more. Started Jan 2023; status: completed.
02
Drugs
chlorhexidinenystatintetracyclineglycerol
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20230119057156N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230119057156N1.